Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
Recent: |
|
Past: |
|
Lilly said people on the drug donanemab slowed decline by 35% based on a measure of daily activities such as driving and talking about current events. → Read More
Two reports show how nurses perceive their profession amid a staffing crisis, growing workloads and stressed hospitals. → Read More
Drugmaker Eli Lilly says it will cut its insulin prices up to 70% and cap out-of-pocket costs for privately insured consumers at $35 a month. → Read More
Here's what the FDA is doing to protect consumers after drugs such as quinapril, Zantac and Metformin were recalled over chemicals linked to cancer. → Read More
About 15 million may lose health insurance in May when the COVID emergency ends. Meanwhile, free vaccines and treatments will end by summer. → Read More
As part of the Inflation Reduction Act, Medicare will negotiate drug prices, limit annual price hikes and cap insulin costs paid by older Americans. → Read More
Federal drug regulators on Friday approved lecanemab, sold under the brand name Leqembi, an Alzheimer’s drug that appears to slow the disease. → Read More
The CDC issued new guidance for doctors who treat pain patients that reverses a 2016 version that was used to sharply curtail opioid prescriptions. → Read More
Kaiser Family Foundation survey reports average cost for an employer-provided health increased just 1% this year. → Read More
A survey finds 18% of adults have high vitality and are healthier, exercise more and less obese. Researchers believe it's a key to overall health. → Read More
The nursing home data is part of the Biden administration's effort to shine a light on an industry that receives substantial federal funding. → Read More
A new report casts doubt on a 2006 Alzheimer’s study, but researchers say it does not undercut the prevailing theory into the origin of the disease. → Read More
Juul must cease sales of its vaping device under the FDA ruling. The ban does not restrict customers from using the products. → Read More
With no clear federal rules on incentives for health screenings, a lawsuit at Yale University spotlights measures that penalize some workers. → Read More
A new study highlights mounting costs of COVID testing paid by taxpayers through federal health programs or consumers who buy private insurance. → Read More
Medicare's proposed rule would limit reporting next year for 10 types of medical complications at hospitals. The agency worries COVID distorts data. → Read More
FDA authorized the Pfizer-BioNTech COVID booster for children ages 5 to 11 five months after they have finished the first two-shot vaccination series. → Read More
The federal government has sent billions in federal aid to states for Medicaid coverage during the pandemic. Millions are at risk of losing coverage. → Read More
Congress authorized robust federal aid to states as long as they agreed to not remove people from Medicaid until the COVID-19 emergency ends. → Read More
Heavy demand for COVID-19 testing attracted lab operators who benefitted from a narrow regulatory loophole while collecting millions in federal funds. → Read More